Managing childhood acute lymphoblastic leukemia in a child with Emery-Dreifuss muscular dystrophy

Authors

  • Aishvarya Diptivilasa Junior Resident, Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, Uttar Pradesh, India
  • Nita Radhakrishnan Associate Professor, Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, Uttar Pradesh, India https://orcid.org/0000-0002-7941-5641
  • Shruti Verma IAP Fellow, Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, Uttar Pradesh, India

DOI:

https://doi.org/10.3126/ajms.v15i1.56842

Keywords:

Cancer; Muscular dystrophy; Cancer genetics

Abstract

Genetics is increasingly being integrated into clinical oncology practice. It is necessary for risk stratification of disease, for prognostication, for recognition of underlying predisposition, and for recognition of potential toxicity and predicting outcomes. The prevalence of genetic syndromes, their clinical significance, effect on cancer, and its treatment have been defined in recent times. In this present work, we describe the challenges we faced while managing a child with acute lymphoblastic leukemia with an underlying rare muscular dystrophy. The details were recorded from case files and prospectively collected data. Dose modification of certain chemotherapeutic drugs was planned to reduce toxicity in the child. The child responded to treatment and is currently in remission. The recognition of genetic entity and their potential interactions with treatment received for cancer is vital to plan the treatment.

Downloads

Download data is not yet available.
Abstract
53
PDF
69

Downloads

Published

2024-01-01

How to Cite

Diptivilasa, A., Radhakrishnan, N., & Verma, S. (2024). Managing childhood acute lymphoblastic leukemia in a child with Emery-Dreifuss muscular dystrophy. Asian Journal of Medical Sciences, 15(1), 272–274. https://doi.org/10.3126/ajms.v15i1.56842

Issue

Section

Case Reports